Skip to main content
. 2017 May;23(5):740–749. doi: 10.3201/eid2305.151417

Table. Clinical and patient characteristics and sequence type diversity of bimBm and bimBp Burkholderia pseudomallei isolates, Australia.

Isolate no. Age, y/sex Risk factors Clinical presentation Outcome MLST genotype
bimBm
MSHR62 23/M None Brainstem encephalitis Survived 148
MSHR435 37/M None Brainstem encephalitis Survived 126
MSHR543 22/F None Skin ulcer Survived 294
MSHR668 53/M None Diffuse encephalitis Survived 129
MSHR1153 59/M DBT Brainstem encephalitis Died 117
MSHR2138 49/F DBT Bacteremia Survived 456
NCTC13178
6/M
None
Brainstem encephalitis
Died
286
bimBp
MSHR305 64/M ALC Encephalitis, myelitis Died 36
MSHR346 49/M ALC, COPD Pneumonia Survived 243
MSHR465 67/M DBT, COPD Pneumonia, septic shock Died 132
MSHR1655 61/F COPD Pneumonia Survived 131
MSHR3709 14/M None Brainstem encephalitis Survived 132
MSHR974* 16/F None Skin ulcer Survived 554
MSHR4237* 45/F None Pneumonia Survived 868
NCTC13179 54/M DBT Skin ulcer Survived 613

*Additional isolates included for internalization and persistence assays. ALC, hazardous alcohol use; COPD, chronic obstructive pulmonary disease; DBT, diabetes; MLST, multilocus sequence typing.